These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6802681)
1. Exaggerated prolactin response of thyrotropin-releasing hormone in women with anovulatory cycles: possible role of endogenous estrogens and effect of bromocriptine. Peillon F; Vincens M; Cesselin F; Doumith R; Mowszowicz I Fertil Steril; 1982 Apr; 37(4):530-5. PubMed ID: 6802681 [TBL] [Abstract][Full Text] [Related]
2. Relationship between pituitary reserve and efficacy of bromocriptine in women with euprolactinemic ovulatory dysfunction. Lin KC Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May; 10(5):222-8. PubMed ID: 8040924 [TBL] [Abstract][Full Text] [Related]
3. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy. Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756 [TBL] [Abstract][Full Text] [Related]
4. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)]. Fukunaga T Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases]. Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705 [TBL] [Abstract][Full Text] [Related]
6. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine. Hirvonen E; Ranta T; Seppäla M J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453 [TBL] [Abstract][Full Text] [Related]
7. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia]. Mori H; Aisaka K; Matsuoka R; Kigawa T Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814 [TBL] [Abstract][Full Text] [Related]
8. [A study on the significance of bromocriptine (CB-154) administration in normoprolactinemic anovulatory women (author's transl)]. Ishimaru T; Mori H; Koh K; Imamichi S; Morisaki M; Kohno A; Yoshida K; Imamura S; Yamabe T Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1583-90. PubMed ID: 7240824 [TBL] [Abstract][Full Text] [Related]
10. Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation. van der Steeg HJ; Bennink HJ Lancet; 1977 Mar; 1(8010):502-4. PubMed ID: 65607 [TBL] [Abstract][Full Text] [Related]
11. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)]. Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631 [TBL] [Abstract][Full Text] [Related]
12. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment. Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619 [TBL] [Abstract][Full Text] [Related]
13. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine. Kamal TJ; Molitch ME Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473 [TBL] [Abstract][Full Text] [Related]
14. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone. Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427 [TBL] [Abstract][Full Text] [Related]
15. Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility. Pepperell RJ; Evans JH; Brown JB; Smith MA; Healy D; Burger HG Br J Obstet Gynaecol; 1977 Jan; 84(1):58-66. PubMed ID: 576585 [TBL] [Abstract][Full Text] [Related]
16. [The mechanism of induction of ovulation by bromocriptine in euprolactinemic anovulation--the role of occult hyperprolactinemia in anovulation]. Mori H; Aisaka K; Matsuoka R; Kigawa T Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):38-47. PubMed ID: 3996685 [TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women. Lin KC; Okamura H; Koshida M; Mori T Fertil Steril; 1986 Nov; 46(5):846-51. PubMed ID: 3096783 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of prolactin-secreting-capacity to circadian profile of prolactin in euprolactinemic women with ovulatory disturbances]. Mori H; Aisaka K; Matsuoka R; Kigawa T Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):287-92. PubMed ID: 3919123 [TBL] [Abstract][Full Text] [Related]